期刊文献+

儿童原发性激素依赖型肾病的临床病理分析 被引量:2

原文传递
导出
摘要 儿童原发性激素依赖型肾病(SDNS)是指患儿对激素治疗敏感,用药后缓解,但激素减量或停药后1个月内复发,恢复用药或再次用药仍然有效,并重复2次以上的原发性肾病。目前SDNS的发病率较高,为提高对SDNS的认识,本研究回顾性分析我院85例原发性SDNS患儿的临床与病理特点。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第1期58-59,共2页 Chinese Journal of Nephrology
  • 相关文献

参考文献6

  • 1Wong W. Idiopathic nephrotic syndrome in New Zealand children, demographic, clinical features, initial management and outcome after twelve-month follow-up: results of a three-year national surveillance study. J Paediatr Child Health, 2007, 43: 337-341.
  • 2Ghedira-Besbes L, Mallek A, Guediche MN. Idiopathic nephrotic syndrome in children: report of 57 cases. Tunis Med, 2003, 81: 702-708.
  • 3Kyrieleis HA, Levtchenko EN, Wetzels JF. Long-term outcome after cyclophosphamide treatment in children with steroid-dependent and frequently relapsing minimal change nephrotic syndrome. Am J Kidney Dis, 2007, 49: 592-597.
  • 4Waldman M, Crew R J, Valeri A, et al. Adult minimalchange disease: clinical characteristics, treatment, and outcomes. Clin J Am Soc Nephrol, 2007, 2: 445-453.
  • 5Gulati S, Sengupta D, Sharma RK, et al. Steroid resistant nephrotic syndrome: role of histopathology. Indian Pediatr, 2006, 43: 55-60.
  • 6陆福明 ,丁小强 ,陈楠 ,钱家麒 ,徐琴君 ,袁伟杰 ,梅长林 ,徐玉兰 ,侯凡凡 ,林善锬 .吗替麦考酚酯治疗原发性肾病综合征的前瞻性多中心临床研究[J].中华肾脏病杂志,2004,20(4):238-241. 被引量:35

二级参考文献8

  • 1黄茂芹 周森 陈裕盛.霉酚酸酯治疗肾病综合征8例观察.中华肾脏病杂志,2000,16(6):386-386.
  • 2Briggs WA, Choi M J, Paul J, et al. Successful mycophenolate mofitel treatment of glomerular disease. J Am Kidney Dis, 1998,31: 213-217.
  • 3Dooley MA, Cosio FG, Nachman PH, et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol, 1999, 10: 833-839.
  • 4Schwarz A. New aspects of the treatment of nephrotic syndrome. J Am Soc Nephrol, 2001, 12: s44-s47.
  • 5Eugui EM, Almquist SJ, Muller CD, et al. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vivo: role of deoxyguanosine nucleotide depletion. Scand J Immunol, 1991,33: 161-173.
  • 6Choi MJ, Eustace JA, Gimenez LF, et al. Mycophenolate mofetil treatment for primary glomerulopathies. J Am Soc Nephrol, 2000,10: A0449.
  • 7胡伟新,刘志红,唐政,姚小丹,王庆文,沈克勤,黎磊石.霉酚酸酯治疗35例Ⅳ型狼疮性肾炎的长期随访[J].肾脏病与透析肾移植杂志,2001,10(1):8-12. 被引量:27
  • 8赵明辉,陈香美,谌贻璞,刘章锁,刘玉春,卢方平,张燕萍,王海燕.霉酚酸酯治疗原发性肾病综合征的临床观察[J].中华医学杂志,2001,81(9):528-531. 被引量:105

共引文献34

同被引文献44

  • 1潘晓霞,陈楠,周伟,王朝晖,张文,王伟铭,陈晓农,巫永睿,陆颖.原发性局灶节段性肾小球硬化患者CD2AP基因突变的研究[J].中华肾脏病杂志,2006,22(1):13-18. 被引量:24
  • 2师素芳,王素霞,章友康,赵明辉,邹万忠.不同病理类型局灶节段性肾小球硬化症的临床病理分析[J].中华病理学杂志,2007,36(1):11-14. 被引量:5
  • 3Schnaper HW, Robson AM, Kopp JB. Nephrotic syndrome: minimal change disease, focal segmental glomerulosclerosis, and collapsing glomerulopathy //Schrier RW. Diseases of the Kidney and Urinary Tract. 8th. Philadelphia: Lippincott Williams & Wilkins, 2006: 1585-1672.
  • 4Pollak MR. Inherited podocytopathies: FSGS and nephrotic syndrome from a genetic viewpoint. J Am Soc Nephrol, 2002, 13: 3016-3023.
  • 5D'Agati V. Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol, 2003, 23: 117-134.
  • 6D'Agati VD, Fogo AB, Bruijn JA, et al. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis, 2004, 43: 368-382.
  • 7Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: a reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol, 2007, 2: 529-542.
  • 8Barisoni L, Schnaper HW, Kopp JB. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med, 2009, 133: 201-216.
  • 9Gipson DS, Chin H, Presler TP, et al. Differential risk of remission and ESRD in childhood FSGS. Pediatr Nephrol, 2006, 21: 344-349.
  • 10Stokes MB, Valeri AM, Markowitz GS, et al. Cellular focal segmental glomerulosclerosis: Clinical and pathologic features. Kidney Int, 2006, 70: 1783-1792.

引证文献2

二级引证文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部